Skip to main content
logo
Neurothera Labs Inc. (TSXV:NTLX)
Canada flag Canada · Delayed Price · Currency is CAD
4.390
+1.030 (30.65%)
Sep 9, 2026, 1:58 PM EST

Neurothera Labs Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-5.2-4.12-2.94
Depreciation & Amortization
0.180.190.37
Asset Writedown & Restructuring Costs
0.120.121.34
Stock-Based Compensation
0.940.380.05
Other Operating Activities
1.131.22-1.19
Change in Accounts Receivable
0.01-0.01
Change in Inventory
0.090.040.63
Change in Accounts Payable
0.210.2-0.03
Change in Other Net Operating Assets
0.920.310.08
Operating Cash Flow
-1.62-1.66-1.69
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Acquisitions
0.830.71-
Other Investing Activities
---0.01
Investing Cash Flow
0.830.71-0.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Long-Term Debt Issued
-1.14-
Net Debt Issued (Repaid)
1.141.14-
Issuance of Common Stock
0.481.391.66
Financing Cash Flow
1.622.531.66

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Cash Flow
0.841.58-0.03

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Levered Free Cash Flow
--0.41-
Unlevered Free Cash Flow
--0.33-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Change in Working Capital
1.220.550.69